Takeda stopped enrolling patients in the trial, again well short of its target, earlier this year. Like TAK-186, TAK-280 used Maverick’s prodrug technology to restrict activation to the tumor ...

We thank Dr. Richard J. Youle at NIH for providing Penta KO HeLa cells. We thank Dr. Kotaro Ishida of Hirosaki University for providing the methods and assisting with the analysis of live-cell imaging ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches. Skip to content. Home page Seeking Alpha - Power to Investors.

Emotions coordinate our behavior and physiological states during survival-salient events and pleasurable interactions. Even though we are often consciously aware of our current emotional state, such ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...

Global biopharmaceutical giant Takeda opens its first Asian Innovation Capability Centre in Bengaluru to speed-up drug discovery and development.

Takeda Pharmaceutical Company ( (TAK) ) has shared an update. Takeda Pharmaceutical Company has submitted an extraordinary report detailing its decision to dissolve its specified subsidiary, Shire ...

Pharmaceutical giant Takeda is shutting down its research and development hub in San Diego that employs 324 as part of a broader restructuring of the business. “This site closure is primarily a ...

Takeda has made some cuts to its clinical-phase pipeline, hacking off midphase programs and early-stage prospects as part of a push to focus on its most promising candidates. Let’s start in phase 2.

Takeda isn’t saying which dose of TAK-279 it plans to advance to Phase 3, but Plump noted that the clear separation on the 100% clearance measure at 30 mg has the company looking closely at ...

Thru-hikers on the Pacific Crest Trail spend up to five months walking from Mexico to Canada — and the imprint of climate change is now felt along the entire route. The increased incidence of ...

Pitcher of the Year: Sam Garewal, Canyon Crest The 6-foot-4, 215-pound senior left-hander was 6-2 this season with a 1.31 ERA. He pitched 691/3 innings and struck out 130 batters.